Rani Therapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary

Rani Therapeutics Holdings

22/03/2023 21:02

* Rani Therapeutics Holdings Inc  RANI.OQ  reported a
quarterly
adjusted loss of 35 cents​​ per share for the quarter ended in
December. The mean expectation of seven analysts for the quarter
was for a loss of 35 cents per share.
    * Reported revenue was zero​; analysts expected $108.33
thousand. 
    * Rani Therapeutics Holdings Inc's reported EPS for the
quarter
was a loss of 35 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Rani Therapeutics Holdings Inc shares had risen by 1.9%
this
quarter.
    * The company reported a quarterly loss of $8.79 million.
    * Wall Street's median 12-month price target for Rani
Therapeutics
Holdings Inc is $23.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.35          -0.35          Met
 Sep. 30 2022      -0.47          -0.33          Beat
 Jun. 30 2022      -0.58          -0.31          Beat
 Mar. 31 2022      -0.66          -0.29          Beat